Autobio Diagnostics Co., Ltd. (SHA:603658)
China
· Delayed Price · Currency is CNY 39.30
-0.03 (-0.08%)
May 13, 2025, 3:00 PM CST
Autobio Diagnostics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 4,296 | 4,389 | 4,368 | 4,366 | 3,686 | 2,898 | Upgrade
|
| Other Revenue | 81.98 | 81.98 | 76.05 | 75.76 | 79.82 | 80.1 | Upgrade
|
| Revenue | 4,378 | 4,471 | 4,444 | 4,442 | 3,766 | 2,978 | Upgrade
|
| Revenue Growth (YoY) | -2.63% | 0.62% | 0.05% | 17.94% | 26.45% | 11.15% | Upgrade
|
| Cost of Revenue | 1,542 | 1,582 | 1,612 | 1,844 | 1,545 | 1,216 | Upgrade
|
| Gross Profit | 2,836 | 2,889 | 2,832 | 2,597 | 2,221 | 1,762 | Upgrade
|
| Selling, General & Admin | 981.61 | 953.05 | 920.21 | 857.11 | 757.02 | 589.91 | Upgrade
|
| Research & Development | 711.35 | 731.93 | 656.13 | 568.48 | 480.96 | 342.8 | Upgrade
|
| Other Operating Expenses | 3.51 | -3.25 | 28.05 | 28.24 | 13.73 | 22.75 | Upgrade
|
| Operating Expenses | 1,741 | 1,737 | 1,626 | 1,471 | 1,267 | 981.61 | Upgrade
|
| Operating Income | 1,095 | 1,152 | 1,206 | 1,126 | 954.28 | 780.48 | Upgrade
|
| Interest Expense | -21.52 | -22.28 | -24.54 | -21.23 | -12.68 | -29.05 | Upgrade
|
| Interest & Investment Income | 109.19 | 112.84 | 144.76 | 135.09 | 116.43 | 61.8 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.63 | 0.63 | 1.19 | 7.47 | -9.65 | -2.76 | Upgrade
|
| Other Non Operating Income (Expenses) | 3 | -2.08 | -2.9 | -5.18 | 0.77 | -15.78 | Upgrade
|
| EBT Excluding Unusual Items | 1,187 | 1,241 | 1,325 | 1,242 | 1,049 | 794.69 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.85 | 3.61 | 0.58 | - | 0.03 | 0.09 | Upgrade
|
| Gain (Loss) on Sale of Assets | -13.35 | -12.2 | -2.78 | -1.72 | -1.17 | -1.13 | Upgrade
|
| Asset Writedown | -53.73 | -52.75 | - | - | - | - | Upgrade
|
| Other Unusual Items | 108.9 | 109.07 | 39.95 | 53.06 | 17.54 | 50.88 | Upgrade
|
| Pretax Income | 1,229 | 1,289 | 1,363 | 1,294 | 1,066 | 844.53 | Upgrade
|
| Income Tax Expense | 85.77 | 89.82 | 138.41 | 105.03 | 85.69 | 87.44 | Upgrade
|
| Earnings From Continuing Operations | 1,144 | 1,199 | 1,224 | 1,189 | 979.86 | 757.09 | Upgrade
|
| Minority Interest in Earnings | -3.49 | -4.78 | -6.69 | -21.25 | -6.19 | -9.3 | Upgrade
|
| Net Income | 1,140 | 1,194 | 1,217 | 1,167 | 973.66 | 747.79 | Upgrade
|
| Net Income to Common | 1,140 | 1,194 | 1,217 | 1,167 | 973.66 | 747.79 | Upgrade
|
| Net Income Growth | -12.27% | -1.89% | 4.28% | 19.90% | 30.20% | -3.41% | Upgrade
|
| Shares Outstanding (Basic) | 576 | 577 | 580 | 584 | 587 | 558 | Upgrade
|
| Shares Outstanding (Diluted) | 576 | 577 | 580 | 584 | 587 | 558 | Upgrade
|
| Shares Change (YoY) | -0.78% | -0.47% | -0.68% | -0.48% | 5.10% | 2.03% | Upgrade
|
| EPS (Basic) | 1.98 | 2.07 | 2.10 | 2.00 | 1.66 | 1.34 | Upgrade
|
| EPS (Diluted) | 1.98 | 2.07 | 2.10 | 2.00 | 1.66 | 1.34 | Upgrade
|
| EPS Growth | -11.58% | -1.43% | 5.00% | 20.48% | 23.88% | -5.33% | Upgrade
|
| Free Cash Flow | 567.06 | 644.88 | 569.44 | 620.1 | 395.39 | -120.67 | Upgrade
|
| Free Cash Flow Per Share | 0.98 | 1.12 | 0.98 | 1.06 | 0.67 | -0.22 | Upgrade
|
| Dividend Per Share | 1.260 | 1.260 | 1.052 | 0.800 | 0.750 | 0.654 | Upgrade
|
| Dividend Growth | 19.76% | 19.76% | 31.51% | 6.67% | 14.71% | -5.56% | Upgrade
|
| Gross Margin | 64.79% | 64.61% | 63.73% | 58.47% | 58.98% | 59.17% | Upgrade
|
| Operating Margin | 25.02% | 25.77% | 27.15% | 25.36% | 25.34% | 26.21% | Upgrade
|
| Profit Margin | 26.04% | 26.71% | 27.40% | 26.28% | 25.86% | 25.11% | Upgrade
|
| Free Cash Flow Margin | 12.95% | 14.42% | 12.81% | 13.96% | 10.50% | -4.05% | Upgrade
|
| EBITDA | 1,567 | 1,616 | 1,642 | 1,544 | 1,340 | 1,082 | Upgrade
|
| EBITDA Margin | 35.78% | 36.15% | 36.96% | 34.76% | 35.59% | 36.33% | Upgrade
|
| D&A For EBITDA | 471.23 | 464.2 | 436.1 | 417.56 | 385.93 | 301.56 | Upgrade
|
| EBIT | 1,095 | 1,152 | 1,206 | 1,126 | 954.28 | 780.48 | Upgrade
|
| EBIT Margin | 25.02% | 25.77% | 27.15% | 25.36% | 25.34% | 26.21% | Upgrade
|
| Effective Tax Rate | 6.98% | 6.97% | 10.16% | 8.12% | 8.04% | 10.35% | Upgrade
|
| Revenue as Reported | 4,378 | 4,471 | 4,444 | 4,442 | 3,766 | 2,978 | Upgrade
|
| Advertising Expenses | - | 54.35 | 55.79 | 41.4 | 45.1 | 32.03 | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.